Klinov S V, Kurganov B I, Chebotareva N A, Zhilina T A, Litvak Zh I
Bioorg Khim. 1988 Aug;14(8):1027-33.
The interaction of rabbit skeletal muscle glycogen phosphorylase b with riboflavin, 2',3',4',5'-tetraacetylriboflavin and their analogues, containing different substituents in the positions 6, 8 and 8 alpha, has been studied. Dissociation constant for the complex of the enzyme and riboflavin was determined to be 12.5 microM (pH 6.8; 20 degrees C) by sedimentation velocity method. Riboflavin and its analogues have been found to inhibit glycogen phosphorylase b. The inhibitor half-saturation concentration values increase in the following order: riboflavin (18 microM), 8-methoxy(nor)rifoblavin (23 microM), 8 alpha-bromo-2',3',4',5'-tetraacetylriboflavin (40 microM), 6-bromoriboflavin (40 microM), 8 alpha-hydroxyriboflavin (60 microM), 8-hydroxy(nor)riboflavin (90 microM), 8 alpha-(gamma-carboxypropylamino-2',3',4',5'-tetraacetylriboflav in (90 microM), 8 alpha-[p-(5-ethyl-1,3,4-thiodiazol-2-ylsulfamido)phenylamino ]- 2',3',4',5'-tetraacetylriboflavin (100 microM), 8 alpha-(L-methionyno)-2',3',4',5'-tetraacetylriboflavin (120 microM), 8 alpha-[p-(thiazol-2-ylsulfamido)phenylamino]- 2',3',4',5'-tetraacetylriboflavin (140 microM), 8 alpha-(p-sulfamidophenylamino)-2',3',4',5'-tetraacetylriboflavi n (180 microM), 8 alpha-(p-carboxyphenylamino)-2',3',4',5'-tetraacetylriboflavin+ ++ (210 microM), 2',3',4',5'-tetraacetylriboflavin (250 microM), 8 alpha-(L-homoserino)-2',3',4',5'-tetraacetylriboflavin (340 microM), 8 alpha-(L-glutamo)-2',3',4',5'-tetraacetylriboflavin (360 microM). The existence of glycogen phosphorylase b complexes with riboflavin and its analogues has been proved by methods of absolute and difference spectrophotometry.
研究了兔骨骼肌糖原磷酸化酶b与核黄素、2',3',4',5'-四乙酰核黄素及其在6、8和8α位含有不同取代基的类似物之间的相互作用。通过沉降速度法测定,该酶与核黄素复合物的解离常数在pH 6.8、20℃时为12.5μM。已发现核黄素及其类似物可抑制糖原磷酸化酶b。抑制剂半饱和浓度值按以下顺序增加:核黄素(18μM)、8-甲氧基(去甲)核黄素(23μM)、8α-溴-2',3',4',5'-四乙酰核黄素(40μM)、6-溴核黄素(40μM)、8α-羟基核黄素(60μM)、8-羟基(去甲)核黄素(90μM)、8α-(γ-羧丙基氨基)-2',3',4',5'-四乙酰核黄素(90μM)、8α-[对-(5-乙基-1,3,4-噻二唑-2-基磺酰胺基)苯氨基]-2',3',4',5'-四乙酰核黄素(100μM)、8α-(L-甲硫氨酰基)-2',3',4',5'-四乙酰核黄素(120μM)、8α-[对-(噻唑-2-基磺酰胺基)苯氨基]-2',3',4',5'-四乙酰核黄素(140μM)、8α-(对-磺酰胺基苯氨基)-2',3',4',5'-四乙酰核黄素(180μM)、8α-(对-羧基苯氨基)-2',3',4',5'-四乙酰核黄素(210μM)、2',3',4',5'-四乙酰核黄素(250μM)、8α-(L-高丝氨酰基)-2',3',4',5'-四乙酰核黄素(340μM)、8α-(L-谷氨酰基)-2',3',4',5'-四乙酰核黄素(360μM)。通过绝对分光光度法和差示分光光度法证明了糖原磷酸化酶b与核黄素及其类似物复合物的存在。